Royce & Associates LP Nuvasive Inc Transaction History

Royce & Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$43.51 - $66.59 $35,808 - $54,803	-823 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$32.82 - $81.13 $27,010 - $66,769	823 New	823 $42,000
Q3 2019 Nov 13, 2019	SELL	$55.78 - $68.08 $31,906 - $38,941	-572 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$53.69 - $65.47 $5,691 - $6,939	-106 Reduced 15.63%	572 $33,000
Q1 2019 May 09, 2019	BUY	$44.53 - $58.9 $7,837 - $10,366	176 Added 35.06%	678 $39,000
Q4 2018 Feb 11, 2019	BUY	$47.64 - $71.26 $23,915 - $35,772	502 New	502 $25,000
Q3 2018 Nov 13, 2018	SELL	$52.03 - $71.41 $18,990 - $26,064	-365 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$48.15 - $56.68 $17,574 - $20,688	365 New	365 $19,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.